Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rinki Deo

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
Annals of Internal Medicine|April 17, 2023
Safety and Efficacy of Combination SARS-CoV-2 Neutralizing Monoclonal Antibodies Amubarvimab Plus Romlusevimab in Nonhospitalized Patients With COVID-19Teresa H Evering, Kara W Chew, Mark J Giganti, et al.
JAMA Network Open|September 25, 2024
Emerging SARS-CoV-2 Resistance After Antiviral TreatmentTrevor J Tamura, Manish C Choudhary, Rinki Deo, et al.
Nature Microbiology|October 27, 2022
Emergence of SARS-CoV-2 escape mutations during Bamlanivimab therapy in a phase II randomized clinical trialManish C Choudhary, Kara W Chew, Rinki Deo, et al.
Medrxiv : the Preprint Server for Health Sciences|September 21, 2021
Emergence of SARS-CoV-2 Resistance with Monoclonal Antibody TherapyManish C Choudhary, Kara W Chew, Rinki Deo, et al.
Plos Pathogens|May 12, 2026
Extensive diversity and impact of drug-resistant HIV-1 variants in individuals with prior virologic failureMelendhran Pillay, Manish C Choudhary, Rinki Deo, et al.
Research Square|December 16, 2024
Cross-neutralization of distant coronaviruses correlates with Spike S2-specific antibodies from immunocompetent and immunocompromised vaccinated SARS-CoV-2-infected patientsSara V Patel, Brooke M Leeman, Patricia J Botros, et al.
Vaccines|September 27, 2025
Cross-Neutralization of Distant Coronaviruses Strongly Correlates with Spike S2-Specific Antibodies from Immunocompetent and Immunocompromised Vaccinated SARS-CoV-2-Infected PatientsSara V Patel, Brooke M Leeman, Patricia J Botros, et al.
Medrxiv : the Preprint Server for Health Sciences|April 10, 2023
Viral and Host Mediators of Non-Suppressible HIV-1 ViremiaAbbas Mohammadi, Behzad Etemad, Xin Zhang, et al.
Science Translational Medicine|January 24, 2024
SARS-CoV-2 viral clearance and evolution varies by type and severity of immunodeficiencyYijia Li, Manish C Choudhary, James Regan, et al.
Medrxiv : the Preprint Server for Health Sciences|August 14, 2023
SARS-CoV-2 Viral Clearance and Evolution Varies by Extent of ImmunodeficiencyYijia Li, Manish C Choudhary, James Regan, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Annals of Internal Medicine|April 17, 2023
Safety and Efficacy of Combination SARS-CoV-2 Neutralizing Monoclonal Antibodies Amubarvimab Plus Romlusevimab in Nonhospitalized Patients With COVID-19Teresa H Evering, Kara W Chew, Mark J Giganti, et al.
JAMA Network Open|September 25, 2024
Emerging SARS-CoV-2 Resistance After Antiviral TreatmentTrevor J Tamura, Manish C Choudhary, Rinki Deo, et al.
Nature Microbiology|October 27, 2022
Emergence of SARS-CoV-2 escape mutations during Bamlanivimab therapy in a phase II randomized clinical trialManish C Choudhary, Kara W Chew, Rinki Deo, et al.
Medrxiv : the Preprint Server for Health Sciences|September 21, 2021
Emergence of SARS-CoV-2 Resistance with Monoclonal Antibody TherapyManish C Choudhary, Kara W Chew, Rinki Deo, et al.
Plos Pathogens|May 12, 2026
Extensive diversity and impact of drug-resistant HIV-1 variants in individuals with prior virologic failureMelendhran Pillay, Manish C Choudhary, Rinki Deo, et al.
Research Square|December 16, 2024
Cross-neutralization of distant coronaviruses correlates with Spike S2-specific antibodies from immunocompetent and immunocompromised vaccinated SARS-CoV-2-infected patientsSara V Patel, Brooke M Leeman, Patricia J Botros, et al.
Vaccines|September 27, 2025
Cross-Neutralization of Distant Coronaviruses Strongly Correlates with Spike S2-Specific Antibodies from Immunocompetent and Immunocompromised Vaccinated SARS-CoV-2-Infected PatientsSara V Patel, Brooke M Leeman, Patricia J Botros, et al.
Medrxiv : the Preprint Server for Health Sciences|April 10, 2023
Viral and Host Mediators of Non-Suppressible HIV-1 ViremiaAbbas Mohammadi, Behzad Etemad, Xin Zhang, et al.
Science Translational Medicine|January 24, 2024
SARS-CoV-2 viral clearance and evolution varies by type and severity of immunodeficiencyYijia Li, Manish C Choudhary, James Regan, et al.
Medrxiv : the Preprint Server for Health Sciences|August 14, 2023
SARS-CoV-2 Viral Clearance and Evolution Varies by Extent of ImmunodeficiencyYijia Li, Manish C Choudhary, James Regan, et al.
Pageof 4